ATE473752T1 - Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung - Google Patents

Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung

Info

Publication number
ATE473752T1
ATE473752T1 AT06724130T AT06724130T ATE473752T1 AT E473752 T1 ATE473752 T1 AT E473752T1 AT 06724130 T AT06724130 T AT 06724130T AT 06724130 T AT06724130 T AT 06724130T AT E473752 T1 ATE473752 T1 AT E473752T1
Authority
AT
Austria
Prior art keywords
cosmetic
synthesis
inducing
compounds
production
Prior art date
Application number
AT06724130T
Other languages
English (en)
Inventor
Farra Claude Dal
Nouha Domloge
Jean-Marie Botto
Original Assignee
Soc Extraction Principes Actif
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Extraction Principes Actif filed Critical Soc Extraction Principes Actif
Application granted granted Critical
Publication of ATE473752T1 publication Critical patent/ATE473752T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
AT06724130T 2005-04-01 2006-03-30 Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung ATE473752T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503202A FR2883752B1 (fr) 2005-04-01 2005-04-01 Utilisation de composes inducteurs de la synthese des proteines sirt dans ou pour la preparation d'une composition cosmetique ou pharmaceutique
PCT/EP2006/003190 WO2006103110A1 (en) 2005-04-01 2006-03-30 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE473752T1 true ATE473752T1 (de) 2010-07-15

Family

ID=35350233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06724130T ATE473752T1 (de) 2005-04-01 2006-03-30 Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung

Country Status (8)

Country Link
US (1) US7842670B2 (de)
EP (1) EP1868631B1 (de)
AT (1) ATE473752T1 (de)
DE (1) DE602006015449D1 (de)
ES (1) ES2347070T3 (de)
FR (1) FR2883752B1 (de)
PL (1) PL1868631T3 (de)
WO (1) WO2006103110A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900826B1 (fr) * 2006-05-12 2008-08-15 Soc Extraction Principes Actif Utilisation de peptides en tant que principes actifs amincissants.
US7749949B2 (en) * 2006-12-15 2010-07-06 Colgate-Palmolive Company Liquid detergent composition comprising an acrylic polymer/ propylene glycol ether of methyl glucose mixture
US20090047309A1 (en) * 2007-08-13 2009-02-19 Maes Daniel H Cosmetic methods and compositions for repairing human skin
US8193155B2 (en) 2009-02-09 2012-06-05 Elc Management, Llc Method and compositions for treating skin
US8703161B2 (en) * 2007-08-13 2014-04-22 Elc Management, Llc Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
FR2961814B1 (fr) * 2010-06-29 2014-09-26 Isp Investments Inc Nouveaux peptides activateurs de la sirtuine 6 et composition cosmetique ou pharmaceutiques les comprenant.
US10383815B2 (en) 2012-09-14 2019-08-20 Elc Management Llc Method and compositions for improving selective catabolysis in cells of keratin surfaces
BR102014014999B1 (pt) * 2014-06-18 2020-12-01 Hypera S.A. combinação para proteção da pele contra danos causados pela radiação infravermelha, composição e uso da combinação

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030064411A1 (en) * 2000-12-08 2003-04-03 Herath Herath Mudiyanselage Athula Chandrasiri Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of Alzheimer's disease
AU2004253579B2 (en) * 2003-07-01 2010-12-23 Biomol International L.P. Sirt1 modulators for manipulating cells/organism lifespan/stress response
US20090012130A1 (en) * 2005-01-25 2009-01-08 The Johns Hopkins University Strategies for Designing Drugs that Target the Sir2 Family of Enzymes

Also Published As

Publication number Publication date
DE602006015449D1 (de) 2010-08-26
ES2347070T3 (es) 2010-10-25
US7842670B2 (en) 2010-11-30
FR2883752A1 (fr) 2006-10-06
PL1868631T3 (pl) 2010-10-29
FR2883752B1 (fr) 2008-04-11
US20090082278A1 (en) 2009-03-26
EP1868631A1 (de) 2007-12-26
EP1868631B1 (de) 2010-07-14
WO2006103110A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
ATE473752T1 (de) Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung
DE602007009995D1 (de) Muteine von tearlipocalin und verfahren zu deren gewinnung
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
ECSP056071A (es) Nueva difenilazetidinona con características fisiológicas mejoradas, correspondiente método de producción, medicamentos que contienen dicho compuesto y su uso
TW200700357A (en) Benzoic acid ester compounds, compositions, uses and methods related thereto
BRPI0620436A8 (pt) compostos miméticos de lisina modificados, composição farmacêutica e uso
TW200745103A (en) Substituted 7-azaindazoles, compositions containing them, production process and use
EP2033688A3 (de) Oxalsäurederivate und deren Verwendung als physiologische Kühlwirkstoffe
ATE425961T1 (de) Salze substituierter allophansaureester und deren verwendung in arzneimitteln
DE602005012513D1 (de) Verwendung eines kreuzblütler-proteinhydrolysats als depigmentierungsmittel oder für eine kosmetische und/oder pharmazeutische zusammensetzung
ATE432710T1 (de) Pharmazeutische zusammensetzungen, die diaminooxidase enthalten
WO2007055905A3 (en) Compositions and methods of vascular injury repair
WO2012143364A3 (en) Cosmetic composition for use in increasing collagen synthesis in skin cells
TW200624128A (en) Gamma-polyglutamic acid (gamma-PGA, h form), gamma-polyglutamates and gamma-polyglutamate hydrogels
ATE476969T1 (de) Verwendung filmbildender haarpflegepolymere aus der gruppe der polyurethane und diese polymere enthaltende pharmazeutische zubereitungen und pflaster
TW200700420A (en) Novel triazolopyrimidine derivatives
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
WO2007003771A3 (fr) Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
BRPI0621347B8 (pt) composição farmacêutica para aumentar a produção de eritrócitos e para o tratamento de anemia
NO20091517L (no) Emulsjon
FR2984735B1 (fr) Composition hydratante
ITMI20052515A1 (it) Formulazione farmaceutica per il trattamento della osteoartrite
WO2007003773A3 (fr) Utilisation d'un extrait de levure en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
ATE424896T1 (de) Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
BRPI0409790A (pt) 7-azaindóis e seu uso como terapêuticos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties